1. HIGH EFFICACY AND SAFETY OF VTD AS AN INDUCTION PROTOCOL IN NEWLY DIAGNOSED MM PATIENTS ELIGIBLE FOR HDT/AUTOSCT – A REPORT OF POLISH MULTIPLE MYELOMA STUDY GROUP. (June 2017) Authors: Hus, I.; Manko, J.; Jawniak, D.; Jurczyszyn, A.; Usnarska‐Zubkiewicz, L.; Sawicki, M.; Charlinski, G.; Razny, M.; Rodzaj, M.; Waszczuk‐Gajda, A.; Drozd‐Sokolowska, J.; Galazka, A.; Swiderska, A.; Poglodek, B.; Pluta, A.; Druzd‐Sitek, A.; Grzasko, N.; Kopinska, A.; Pasternak, A.; Blonska, D. Journal: Hematological oncology Issue: Volume 35(2017)Supplement 2 Page Start: 387 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. OFATUMUMAB WITH IVAC FOR DLBCL PATIENTS WHO FAILED R‐CHOP AND WERE NOT CANDIDATES FOR HIGH‐DOSE THERAPY AND ASCT ‐ PHASE 2 TRIAL OF THE POLISH LYMPHOMA RESEARCH GROUP (PLRG‐8). (12th June 2019) Authors: Paszkiewicz‐Kozik, E.; Michalski, W.; Taszner, M.; Knopińska‐Posłuszny, W.; Mordak‐Domagała, M.; Najda, J.; Borawska, A.; Romejko‐Jarosińska, J.; Chełstowska, M.; Świerkowska, M.; Dąbrowska‐Iwanicka, A.; Malenda, A.; Druzd‐Sitek, A.; Konecki, R.; Kuniega, B.; Osowiecki, M.; Ostrowska, B.; Szpila,... Journal: Hematological oncology Issue: Volume 37(2019)Supplement 2 Page Start: 436 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗